Pharmaceuticals.jpg

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

13171-25-0

Trimetazidine 2HCl

13171-25-0
83-67-0

Theobromine

83-67-0
58-55-9

Theophylline

58-55-9
64-75-5

Tetracycline HCl

64-75-5
1401-69-0

Tylosin

1401-69-0
36282-47-0

Tramadol HCl

36282-47-0
162635-04-3

Temsirolimus

162635-04-3
52-24-4

Thiotepa

52-24-4
846-50-4

Temazepam

846-50-4
25332-39-2

Trazodone HCl

25332-39-2
10540-29-1

Tamoxifen

10540-29-1
1098-60-8

Triflupromazine HCl

1098-60-8
1405-54-5

Tylosine tartrate

1405-54-5
3644-61-9

Tolperisone hydrochloride

3644-61-9
548-90-3

Trichodesmine

548-90-3
57648-21-2

Timiperone

57648-21-2
158063-66-2

4-(Trifluoromethyl)nicotinic acid TFNA

158063-66-2
119413-54-6

Topotecan HCl

119413-54-6
108050-54-0

Tilmicosin

108050-54-0
115-37-7

Thebaine

115-37-7